DENISE DARLING: Open Payments
NPI 1750835831 · ELMSFORD, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,842 in 15 payments from 13 companies in 2025. Trend: 2023 $3,668 · 2024 $4,828 · 2025 $1,842
Food & beverage: $1,842
| Company | Payments | Amount |
|---|---|---|
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 3 | $402 |
| Abbott Laboratories | 1 | $161 |
| Janssen Pharmaceuticals, Inc | 1 | $150 |
| Teva Pharmaceuticals USA, Inc. | 1 | $138 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $126 |
| E.R. Squibb & Sons, L.L.C. | 1 | $125 |
| Grifols USA, LLC | 1 | $125 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $125 |
| Viatris Specialty LLC | 1 | $122 |
| Lilly USA, LLC | 1 | $122 |
Products named: FREESTYLE LIBRE 3, INVEGA SUSTENNA, CAPLYTA, COBENFY, HyperRAB, ENTYVIO, YUPELRI, KISUNLA.
Industry payments across NY — which companies pay providers there.
